China Botanic Pharmaceutical Inc



PE Ratio
Market Cap
52 Week Range
$0.0001 - $0.15
Operating Margin
Dividend & Yield
$0 (0.00%)
Rev. per Share

About China Botanic Pharmaceutical Inc

China Botanic Pharmaceutical Inc. researches, develops, manufactures, and distributes of botanical products, bio-pharmaceutical products, and traditional Chinese medicines in the People's Republic of China. It offers botanical anti-depression and nerve-regulation products, including Acanthopanax, a Siberian ginseng that regulates the nervous system, delays aging process, strengthens the body, and treats neurasthenia, insomnia, cerebrovascular and cardiovascular diseases, and fatigue; Tianma tablets and compound Yangjiao tablets, which are botanic drugs for treating headaches and regulate nerves; and compound Schisandra tablets, a botanic drug used to regulate central nervous system, generate body fluids and alleviate thirst, nourish the kidneys, and cure insomnia and palpitations, as well as to cure neurasthenia. The company's biopharmaceutical products consist of Ginseng and Venison Extract, which comprises nutrients that nourish the blood and kidneys, and restore body's energy; and Badger oil expels that treats water and fire burns, scalds, and skin pain. Its botanical antibiotics and traditional over the counter Chinese medicines include Banlangen antiviral and broad-spectrum antibiotic granules; compound Honeysuckle antiviral, antibacterial, and anti-inflammatory granules; Shengmai granules, which regulate blood flow, strengthen heart beat, and improve the immune system and blood quality; and Qing Re Jie Du Oral Liquid that treats flu, upper respiratory infections, and sore throats. The company distributes its products through a network of approximately 3,000 distributors and approximately 70 sales centers. The company was formerly known as Renhuang Pharmaceuticals, Inc. and changed its name to China Botanic Pharmaceutical Inc. in November 2010. China Botanic Pharmaceutical Inc. was founded in 1996 and is headquartered in Harbin, China.


News about China Botanic Pharmaceutical Inc

China Botanic Pharmaceutical Inc

About kinfo
Kinfo is an app for DIY traders and investors. Kinfo tracks your trading performance and lets you compare measurable performance metrics against other traders. Kinfo works for day trading, swing trading and longer holding periods. By tracking portfolio performance kinfo allows traders to learn, find inspiration and gain confidence.
Get Social
Download the App

Trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.

Never risk more than you are willing to lose. Trading futures and other derivatives may cause losses that exceed deposits.

Hypothetical performance results have inherent limitations, some of which are described below. Kinfo makes no representation that any trading account will or is likely to achieve profits or losses like those shown. There are often sharp differences between hypothetical trading performance results and the actual results subsequently achieved by any trading program. Past results of advertised trading systems, profit statements, charts or any other representations are not indicative of future performance.

Kinfo is an educational site and is not a financial adviser or broker. All stocks, ETFs, commodities, Indices, Forex, Bonds, and other securities mentioned in our courses are for educational and illustrative purposes only. If you need professional investment advice, please consult a registered investment adviser. Futures and Options carry risk and may not be suitable for everyone.

Kinfo demonstrates specific advanced approaches (or methods). Any mention of Return of Investment percentages is only indicative of the potential of the strategy or the system and is not meant to signify any guaranteed returns.

Success in trading involves a range of human factors like decision making skills, adjustment skills, emotional control, and risk management and other psychological and behavioral parameters, all of which are completely in the hands of the individual. Trading involves significant risk of loss. It is not suitable for all investors.

Charts on kinfo provided by TradingView